NO158135C - Analogifremgangsmaate til fremstilling av terapeutisk aktive pyridazinoner. - Google Patents

Analogifremgangsmaate til fremstilling av terapeutisk aktive pyridazinoner.

Info

Publication number
NO158135C
NO158135C NO820670A NO820670A NO158135C NO 158135 C NO158135 C NO 158135C NO 820670 A NO820670 A NO 820670A NO 820670 A NO820670 A NO 820670A NO 158135 C NO158135 C NO 158135C
Authority
NO
Norway
Prior art keywords
pyridazinons
preparation
therapeutically active
analogy procedure
compounds
Prior art date
Application number
NO820670A
Other languages
English (en)
Norwegian (no)
Other versions
NO820670L (no
NO158135B (no
Inventor
Richard Goeschke
Original Assignee
Ciba Geigy Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ciba Geigy Ag filed Critical Ciba Geigy Ag
Publication of NO820670L publication Critical patent/NO820670L/no
Publication of NO158135B publication Critical patent/NO158135B/no
Publication of NO158135C publication Critical patent/NO158135C/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D295/00Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/16Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms
    • C07D295/18Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms by radicals derived from carboxylic acids, or sulfur or nitrogen analogues thereof
    • C07D295/182Radicals derived from carboxylic acids
    • C07D295/185Radicals derived from carboxylic acids from aliphatic carboxylic acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D237/00Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
    • C07D237/02Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings
    • C07D237/04Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having less than three double bonds between ring members or between ring members and non-ring members
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D295/00Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/14Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D295/155Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with the ring nitrogen atoms and the carbon atoms with three bonds to hetero atoms separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Diabetes (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Hematology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Chemical And Physical Treatments For Wood And The Like (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Curing Cements, Concrete, And Artificial Stone (AREA)
  • Medicinal Preparation (AREA)
  • Treating Waste Gases (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Plural Heterocyclic Compounds (AREA)
NO820670A 1981-03-04 1982-03-03 Analogifremgangsmaate til fremstilling av terapeutisk aktive pyridazinoner. NO158135C (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH144381 1981-03-04

Publications (3)

Publication Number Publication Date
NO820670L NO820670L (no) 1982-09-06
NO158135B NO158135B (no) 1988-04-11
NO158135C true NO158135C (no) 1988-07-20

Family

ID=4210578

Family Applications (1)

Application Number Title Priority Date Filing Date
NO820670A NO158135C (no) 1981-03-04 1982-03-03 Analogifremgangsmaate til fremstilling av terapeutisk aktive pyridazinoner.

Country Status (24)

Country Link
US (3) US4613599A (fi)
EP (1) EP0059688B1 (fi)
JP (1) JPS57158762A (fi)
AT (1) ATE13294T1 (fi)
AU (1) AU558039B2 (fi)
CA (1) CA1180703A (fi)
CY (1) CY1396A (fi)
DD (1) DD209461A5 (fi)
DE (1) DE3263497D1 (fi)
DK (1) DK148772C (fi)
ES (4) ES8308561A1 (fi)
FI (1) FI72718C (fi)
GB (1) GB2094302B (fi)
GR (1) GR81397B (fi)
HK (1) HK87687A (fi)
HU (1) HU191083B (fi)
IE (1) IE52672B1 (fi)
IL (1) IL65161A (fi)
MY (1) MY8700736A (fi)
NO (1) NO158135C (fi)
NZ (1) NZ199892A (fi)
PT (1) PT74520B (fi)
SG (1) SG59587G (fi)
ZA (1) ZA821397B (fi)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4734415A (en) * 1982-08-13 1988-03-29 Warner-Lambert Company Substituted 4,5-dihydro-6-(substituted)-phenyl-3(2H)-pyridazinones and 6-(substituted) phenyl-3(2H)-pyridazinones
GB8400863D0 (en) * 1984-01-13 1984-02-15 Smith Kline French Lab Chemical compounds
GB8426804D0 (en) * 1984-10-23 1984-11-28 Ciba Geigy Ag Pyridazinones preparations
JPS61158969A (ja) * 1984-12-24 1986-07-18 ワーナー‐ランバート・コンパニー 4,5‐ジヒドロ‐4,4‐ジアルキル‐6‐(置換)フエニル‐3(2h)‐ピリダジノン類
IL79280A (en) * 1985-07-05 1990-07-12 Smith Kline French Lab 4-(6-oxo-dihydro or tetrahydropyridazin-3-yl)benzene derivatives,their preparation and pharmaceutical compositions containing them
US4970210A (en) * 1987-07-17 1990-11-13 Abbott Laboratories Triazinone lipoxygenase compounds
DE3735207A1 (de) * 1987-10-17 1989-04-27 Basf Ag Mittel auf der basis von phenylpyridazinon-derivaten zur wachstumsfoerderung und fettreduktion bei tieren
US9890127B2 (en) * 2013-03-11 2018-02-13 The Broad Institute, Inc. Compounds and compositions for the treatment of cancer
WO2019025554A1 (en) * 2017-08-04 2019-02-07 Bayer Aktiengesellschaft 6-PHENYL-4,5-DIHYDROPYRIDAZIN-3 (2H) -ONE DERIVATIVES AS INHIBITORS OF PDE3A AND PDE3B FOR THE TREATMENT OF CANCER
JOP20200024A1 (ar) 2017-08-04 2020-02-02 Bayer Ag مركبات ثنائي هيدروكساديازينون

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US1488330A (en) * 1923-02-01 1924-03-25 Everitt James Clothes-hanging bar formed of hinged-together members
IL37788A0 (en) * 1970-10-09 1971-12-29 American Cyanamid Co New pyridazinone compounds,their preparation and pharmaceutical compositions containing them
GB1383906A (en) * 1971-02-22 1974-02-12 Bdh Pharmaceuticals Ltd Pyridazinones
US3975388A (en) * 1971-02-22 1976-08-17 Bdh Pharmaceuticals Limited Pyridazinones
GB1488330A (en) * 1973-12-19 1977-10-12 Smith Kline French Lab Dihydropyridazinones
DE2854191A1 (de) * 1978-12-15 1980-07-03 Basf Ag Dihydropyridazinone, verfahren zu ihrer herstellung und diese verbindungen enthaltende therapeutische mittel

Also Published As

Publication number Publication date
NO820670L (no) 1982-09-06
DK148772C (da) 1986-05-12
IL65161A0 (en) 1982-05-31
ES510055A0 (es) 1983-09-16
ZA821397B (en) 1983-01-26
AU8106582A (en) 1982-09-09
GR81397B (fi) 1984-12-11
PT74520B (de) 1984-11-19
PT74520A (de) 1982-04-01
NO158135B (no) 1988-04-11
HK87687A (en) 1987-12-04
US4654340A (en) 1987-03-31
US4704391A (en) 1987-11-03
DK91782A (da) 1982-09-05
DD209461A5 (de) 1984-05-09
US4613599A (en) 1986-09-23
ES520024A0 (es) 1984-04-01
NZ199892A (en) 1985-05-31
ES520022A0 (es) 1984-04-01
DE3263497D1 (en) 1985-06-20
HU191083B (en) 1987-01-28
MY8700736A (en) 1987-12-31
IE820478L (en) 1982-09-04
GB2094302A (en) 1982-09-15
ES8308561A1 (es) 1983-09-16
CY1396A (en) 1987-12-18
FI820699L (fi) 1982-09-05
JPS57158762A (en) 1982-09-30
IL65161A (en) 1985-05-31
EP0059688B1 (de) 1985-05-15
ATE13294T1 (de) 1985-06-15
ES520023A0 (es) 1984-04-01
EP0059688A1 (de) 1982-09-08
ES8403892A1 (es) 1984-04-01
IE52672B1 (en) 1988-01-20
FI72718C (fi) 1987-07-10
FI72718B (fi) 1987-03-31
SG59587G (en) 1987-10-23
ES8403893A1 (es) 1984-04-01
GB2094302B (en) 1984-10-10
AU558039B2 (en) 1987-01-15
DK148772B (da) 1985-09-23
ES8403894A1 (es) 1984-04-01
CA1180703A (en) 1985-01-08

Similar Documents

Publication Publication Date Title
ES518227A0 (es) Procedimiento para preparar nuevos compuestos de cefem.
AU561450B2 (en) 2-amino-3-acylamino-6-benzylamino pyridine derivatives
NO158135C (no) Analogifremgangsmaate til fremstilling av terapeutisk aktive pyridazinoner.
DK163144C (da) Diethylaminoalkoxybenzhydrolderivater og farmaceutisk acceptable syreadditionssalte og kvaternaere ammoniumsalte deraf, fremgangsmaade til fremstilling heraf, farmaceutisk praeparat og fremgangsmaade til fremstilling heraf
ATE39920T1 (de) Cyclopentylether, verfahren zu ihrer herstellung und ihre pharmazeutische anwendung.
DE3566666D1 (en) Substituted pyridazinones, method for their preparation, pharmaceutical preparation containing these compounds and their use
NO151465C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive imidazolderivater og syreaddisjonssalter derav
NO157214C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive imidazolcarboxylsyrederivater.
ZA807905B (en) 2-phenylamino-imidazolines-(2),compositions thereof and process for the preparation thereof
ES511836A0 (es) "procedimiento para la preparacion de nuevos a1-pirrolin-tiolactimeteres".
JPS57206683A (en) Pyrimidone salt, manufacture and medicinal composition containing same
DK333081A (da) Fremgangsmaade til fremstilling af 2-(4-hydroxyalkyl-1-piperazinyl)-2,4,6-cycloheptatrien-1-onderivater eller terapeutisk aacceptable syreadditionssalte deraf
JPS5430192A (en) 2-(4-(2-hydroxyethyl)-1-piperazinylmethyl)-5-phenyloxazoles and their pharmaceutically permissible acid addition salt
DK149121C (da) Fremgangsmaade til fremstilling af syreadditionssalte af 3,4-diacyloxy-alfa-((methylamino)-methyl)-benzylalkohol